bladder cancer	is a	malignancy
bladder cancer	originates in	urothelium
bladder cancer	is diagnosed with	cystoscopy
bladder cancer	is staged by	TNM system
bladder cancer	is graded by	WHO classification
bladder cancer	is treated with	transurethral resection
bladder cancer	is treated with	radical cystectomy
bladder cancer	is treated with	intravesical therapy
bladder cancer	is treated with	chemotherapy
bladder cancer	is treated with	radiation therapy
bladder cancer	is treated with	immunotherapy
bladder cancer	is treated with	targeted therapy
bladder cancer	is associated with	smoking
bladder cancer	is associated with	occupational exposure
bladder cancer	is associated with	schistosomiasis
bladder cancer	is associated with	chronic cystitis
bladder cancer	is associated with	bladder stones
bladder cancer	is associated with	HPV infection
bladder cancer	is associated with	diabetes
bladder cancer	is associated with	obesity
bladder cancer	is associated with	hypertension
bladder cancer	is associated with	family history
bladder cancer	increases risk of	upper tract urothelial carcinoma
bladder cancer	increases risk of	second primary cancers
bladder cancer	increases risk of	recurrence
bladder cancer	increases risk of	progression
bladder cancer	increases risk of	mortality
bladder cancer	increases risk of	readmission
bladder cancer	increases risk of	urinary incontinence
bladder cancer	increases risk of	anemia
bladder cancer	increases risk of	renal dysfunction
bladder cancer	increases risk of	infection
bladder cancer	increases risk of	surgical complications
bladder cancer	increases risk of	chemotherapy toxicity
bladder cancer	increases risk of	radiation cystitis
bladder cancer	increases risk of	immunotherapy adverse events
bladder cancer	is predicted by	age
bladder cancer	is predicted by	gender
bladder cancer	is predicted by	smoking status
bladder cancer	is predicted by	occupational exposure
bladder cancer	is predicted by	comorbidity score
bladder cancer	is predicted by	tumor grade
bladder cancer	is predicted by	tumor stage
bladder cancer	is predicted by	lymphovascular invasion
bladder cancer	is predicted by	hematuria
bladder cancer	is predicted by	cystoscopy findings
bladder cancer	is predicted by	imaging results
bladder cancer	is predicted by	biomarker levels
bladder cancer	is predicted by	genetic mutations
bladder cancer	is predicted by	epigenetic changes
bladder cancer	is predicted by	immune profile
bladder cancer	is predicted by	patient-reported symptoms
bladder cancer	is predicted by	socioeconomic status
bladder cancer	is predicted by	health literacy
bladder cancer	is predicted by	medication adherence
bladder cancer	is predicted by	follow‑up interval
bladder cancer	is predicted by	surveillance cystoscopy frequency
bladder cancer	is predicted by	intravesical therapy response
bladder cancer	is predicted by	chemotherapy response
bladder cancer	is predicted by	radiation dose
bladder cancer	is predicted by	immunotherapy response
bladder cancer	is predicted by	targeted therapy response
bladder cancer	is predicted by	tumor mutational burden
bladder cancer	is predicted by	PD‑L1 expression
bladder cancer	is predicted by	FGFR3 mutation
bladder cancer	is predicted by	ERBB2 amplification
bladder cancer	is predicted by	PIK3CA mutation
bladder cancer	is predicted by	TP53 mutation
bladder cancer	is predicted by	DNA repair defects
bladder cancer	is predicted by	circulating tumor DNA
bladder cancer	is predicted by	urinary DNA methylation
bladder cancer	is predicted by	urinary protein markers
bladder cancer	is predicted by	urinary cytology
bladder cancer	is predicted by	imaging radiomics
bladder cancer	is predicted by	machine learning model
bladder cancer	is predicted by	deep learning algorithm
bladder cancer	is predicted by	electronic health record data
bladder cancer	is predicted by	patient‑specific risk score
bladder cancer	is predicted by	nomogram
bladder cancer	is predicted by	decision tree
bladder cancer	is predicted by	random forest
bladder cancer	is predicted by	support vector machine
bladder cancer	is predicted by	Bayesian network
bladder cancer	is predicted by	reinforcement learning
bladder cancer	is treated with	BCG vaccine
bladder cancer	is treated with	gemcitabine
bladder cancer	is treated with	cisplatin
bladder cancer	is treated with	carboplatin
bladder cancer	is treated with	pembrolizumab
bladder cancer	is treated with	atezolizumab
bladder cancer	is treated with	enfortumab
bladder cancer	is treated with	erdafitinib
bladder cancer	is treated with	sacituzumab
bladder cancer	is treated with	radium‑223
bladder cancer	is treated with	hyperthermic intraperitoneal chemotherapy
bladder cancer	is treated with	gene therapy
bladder cancer	is treated with	photodynamic therapy
bladder cancer	is treated with	cryotherapy
bladder cancer	is treated with	watchful waiting
bladder cancer	is treated with	palliative care
